Skip to main content
. 2017 Aug;60(4):260–265. doi: 10.1503/cjs.005316

Table 1.

Demographic and clinical characteristics of patients undergoing RATS (n = 167)

Characteristic No. (%) or median [IQR]
Age, yr 66 [60–74]
Male sex 77 (46.1)
Smoking status
 Smoker 37 (22.2)
 Former smoker 75 (44.9)
 Nonsmoker 51 (30.5)
 Unknown 4 (2.4)
Previous cancer 47 (28.1)
Previous lung resection 4 (2.4)
Tumour location
 Right upper lobe 65 (38.9)
 Right middle lobe 19 (11.4)
 Right lower lobe 32 (19.2)
 Left upper lobe 27 (16.2)
 Left lower lobe 24 (14.4)
Tumour size, cm 2.5 [1.5–3.2]
Resection type
 Lobectomy 141 (84.4)
 Segmental resection 13 (7.8)
 Nonanatomic (wedge) 8 (4.8)
 Bilobectomy 5 (3.0)
T stage
 T1 86 (51.5)
 T2 54 (32.3)
 T3 7 (4.2)
 T4 2 (1.2)
 Benign 10 (6.0)
 Metastases to lung 8 (4.8)
Cumulative stage
 Occult cancer 2 (1)
 1A 71 (43)
 1B 40 (24)
 2A 15 (9)
 2B 6 (4)
 3A 14 (8)
 4 7 (4)
 Benign tumour 10 (6)
FEV1, % predicted 85 [71–94]
DLCO, % predicted 80 [69–93]

DLCO = diffusing capacity of the lungs for carbon monoxide; FEV1 = forced expiratory volume in 1 second; IQR = interquartile range; RATS = robotic-assisted thoracic surgery.